RE-BVS – Piemonte Repository

Sfoglia per AUTORE
MARTINELLI G
Collezione AOU Novara

Items : 7

Long-term survival can be achieved in a significant fraction of older patients with core-binding factor acute myeloid leukemia treated with intensive chemotherapy. in Haematologica / Haematologica. 2025 Mar 1;110(3):608-620. doi: 10.3324/haematol.2024.285448.

2025
AOU Città della Salute di Torino
AOU Novara

Huls G; Valent P; Eisfeld AK; Albano F; Visani G; DiBona E; Roti G; Rigolin GM; Marvalle D; Audisio E; Festuccia M; Venditti A; Forghieri F; Galimberti S; Lanza F; Pullarkat S; Lunghi M; Gotlib JR; Candoni A; Capelli D; Deeg HJ; Gurrieri C; Yeung CCS; Cairoli R; Morgan EA; Ferrara F; Marcucci G; Papayannidis C; Tecchio C; et alii...

Upfront intensive treatment analysis of the Italian Cohort Study on FLT3-mutated AML patients (FLAM): The impact of a FLT3 inhibitor addition to standard chemotherapy in the real-life setting. in Cancer / Cancer. 2025 Apr 1;131(7):e35824. doi: 10.1002/cncr.35824.

2025
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Marconi G; Petracci E; Valli I; Volpi R; Zamagni F; Mattei A; Ottaviani E; Bochicchio MT; Bocchia M; Todisco E; Cilloni D; Rigolin GM; Giannini MB; Bernardi M; Romani C; Fracchiolla N; Olivieri A; Albano F; Lunghi M; Cambò B; Candoni A; Scappini B; Chiusolo P; Audisio E; Martelli MP; Martinelli G; Mulè A; Papayannidis C; Azzali I; et alii...

Current Therapeutic Sequencing in Chronic Lymphocytic Leukemia. in Hematology reports / Hematol Rep. 2024 Apr 30;16(2):270-282. doi: 10.3390/hematolrep16020027.

2024
AOU Novara

Mouhssine S; Maher N; Kogila S; Cerchione C; Martinelli G; Gaidano G;

AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia. in Cancer / Cancer. 2023 Apr 1;129(7):992-1004. doi: 10.1002/cncr.34608. Epub 2023 Jan 24.

2023
AO Cuneo
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Martinelli G; Rossi G; Volpi R; Sciumè M; Tarella C; Marconi G; Federico V; Romano A; Cardinali V; Gigli F; Roncoroni E; Ferrara F; Maurillo L; Nanni J; Rivellini F; Cascavilla N; Fianchi L; Cilloni D; Lanza F; Abruzzese E; Martini V; Lunghi M; Molteni A; Gottardi M; Salutari P; Cairoli R; Borlenghi E; Basilico CM; Manfra I; et alii...

Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group. in British journal of haematology / Br J Haematol. 2014 Jul;166(1):69-76. doi: 10.1111/bjh.12845. Epub 2014 Mar 27.

2014
AOU Novara

Conconi A; Raderer M; Franceschetti S; Devizzi L; Ferreri AJ; Magagnoli M; Arcaini L; Zinzani PL; Martinelli G; Vitolo U; Kiesewetter B; Porro E; Stathis A; Gaidano G; Cavalli F; Zucca E;

Clinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG). in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2011 Mar;22(3):689-695. doi: 10.1093/annonc/mdq416. Epub 2010 Sep 1.

2011
AOU Novara

Conconi A; Martinelli G; Lopez-Guillermo A; Zinzani PL; Ferreri AJM; Rigacci L; Devizzi L; Vitolo U; Luminari S; Cavalli F; Zucca E;

BCR/ABL rearrangement and leukemia phenotype. in Leukemia / Leukemia. 1999 Apr;13 Suppl 1:S96. doi: 10.1038/sj.leu.2401321.

1999
AOU Novara

Saglio G; Pane F; Martinelli G; Guerrasio A;